63.60
-2.51
(-3.80%)
At close: January 24 at 3:54:24 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
17,522,712.00
16,821,343.00
14,139,548.00
15,415,651.00
11,753,673.00
Cost of Revenue
11,025,721.00
10,835,229.00
9,703,728.00
10,609,373.00
7,867,766.00
Gross Profit
6,496,991.00
5,986,114.00
4,435,820.00
4,806,278.00
3,885,907.00
Operating Expense
4,807,175.00
4,734,563.00
3,919,795.00
3,715,980.00
3,003,598.00
Operating Income
1,689,816.00
1,251,551.00
516,025.00
1,090,298.00
882,309.00
Net Non Operating Interest Income Expense
-27,957.00
-12,061.00
-3,234.00
-10,963.00
3,461.00
Pretax Income
1,804,110.00
1,354,157.00
557,553.00
1,267,026.00
985,115.00
Tax Provision
486,629.00
387,954.00
170,798.00
250,213.00
14,215.00
Net Income Common Stockholders
1,312,871.00
961,599.00
386,752.00
1,016,827.00
970,859.00
Diluted NI Available to Com Stockholders
1,312,871.00
961,599.00
386,752.00
1,016,827.00
970,859.00
Basic EPS
2.53
1.88
0.77
2.26
2.16
Diluted EPS
2.53
1.88
0.77
1.96
2.15
Basic Average Shares
519,517.23
511,168.71
502,206.57
449,979.63
449,826.20
Diluted Average Shares
519,517.23
511,168.71
502,206.57
519,826.20
451,072.78
Rent Expense Supplemental
--
120,812.00
107,401.00
81,823.00
51,400.00
Total Expenses
15,832,896.00
15,569,792.00
13,623,523.00
14,325,353.00
10,871,364.00
Net Income from Continuing & Discontinued Operation
1,312,871.00
961,599.00
386,752.00
1,016,827.00
970,859.00
Normalized Income
1,312,871.00
961,599.00
386,752.00
1,016,827.00
970,859.00
Interest Income
--
25,041.00
16,574.00
13,298.00
21,343.00
Interest Expense
52,998.00
37,102.00
19,808.00
24,261.00
12,990.00
Net Interest Income
-27,957.00
-12,061.00
-3,234.00
-10,963.00
3,461.00
EBIT
1,857,108.00
1,391,259.00
577,361.00
1,291,287.00
998,105.00
EBITDA
2,113,633.00
1,725,954.00
856,665.00
1,567,712.00
1,300,938.00
Reconciled Cost of Revenue
11,025,721.00
10,835,229.00
9,703,728.00
10,609,373.00
7,867,766.00
Reconciled Depreciation
256,525.00
334,695.00
279,304.00
276,425.00
302,833.00
Net Income from Continuing Operation Net Minority Interest
1,312,871.00
961,599.00
386,752.00
1,016,827.00
970,859.00
Normalized EBITDA
2,113,633.00
1,725,954.00
856,665.00
1,567,712.00
1,300,938.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
3/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BALAXI.NS Balaxi Pharmaceuticals Limited
70.81
-3.04%
VEERHEALTH.BO Veerhealth Care Limited
18.59
-4.13%
RPGLIFE.BO RPG Life Sciences Limited
2,077.40
-4.12%
EVERESTO.BO Everest Organics Limited
265.00
-1.83%
LAURUSLABS.BO Laurus Labs Limited
601.25
+2.79%
JAGSNPHARM.BO Jagsonpal Pharmaceuticals Limited
244.60
-4.34%
BAJAJHCARE.BO Bajaj HealthCare Limited
558.55
-5.16%
PPLPHARMA.BO Piramal Pharma Limited
233.00
-2.82%
MANKIND.BO Mankind Pharma Limited
2,505.85
-4.82%
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
244.55
-4.06%